Other
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Albemarle Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation decreased by 522.8% to -$528.19M in Q1 2026 compared to the prior quarter.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2025
Last reportedQ1 2026May 6, 2026
Metric ID:
other_cash_cash_equivalents_restricted_cash_and_restrict_8b4577Historical Data
4 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $326.28M | $288.32M | $124.93M | -$528.19M |
| QoQ Change | — | -11.6% | -56.7% | -522.8% |
| YoY Change | — | — | — | -261.9% |
Range-$528.19M – $326.28M
Avg YoY Growth-261.9%
Median YoY Growth-261.9%
Current Streak3+ quarters decline
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Albemarle's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
- Albemarle (ALB) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of -$528.19M in Q1 2026.